跳至主要内容
临床试验/IRCT20141102019783N4
IRCT20141102019783N4招募中3 期

Evaluation of using scalp cooling caps in prevention of chemotherapy-induced alopecia

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • consent for using the cap and filling on the questionnaire
  • using chemotherapy regimens resulting in total alopecia including: 1. Doxorobicin plus cyclophosphamide followed by one of the Taxane drugs (in one, two or three-week regimens) 2. BEP regimen in gonadal malignanciy 3. FEC (5Fu-Epirubicin -cyclophosphamaid) regimen 4. VAC (vincristin-Doxorobicin -cyclophosphamaid) regimen in sarcomas
  • performance higher than 70%
  • age between 18 to 75 years

排除标准

  • Blood malignancies
  • Liver or kidney dysfunction
  • History of cryoglobulinemia
  • Systemic lupus erythematosus
  • No consent for using the caps

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验